Jail-to-Community injection program tests best way to fight opioid relapse
NCT ID NCT04408313
Summary
This study compares two long-acting injectable medications for people with opioid addiction who are leaving jail. 240 participants in Maryland jails will receive either monthly buprenorphine or naltrexone injections starting in jail and continuing for 6 months after release. Researchers will track which treatment helps people stay on their medication, avoid opioid use, and have better health and life outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Friends Research Institute
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.